Stanford Synchrotron Radiation Lightsource (SSRL)

SLAC study shows the so-called ‘pseudogap’ hoards electrons that otherwise might pair up to carry current through a material with 100 percent efficiency.

Understanding details of a flu antibody offers new insight for future structure-based drug discovery and novel avenues for designing vaccines.

Scientists at the Department of Energy’s SLAC National Accelerator Laboratory are combining the speed and precision of robots with one of the brightest X-ray lasers on the planet for pioneering studies of proteins important to biology and drug discovery.

More than a dozen energy-storage companies have streamlined access to research facilities and expertise at SLAC under a new cooperative R&D agreement with CalCharge.

A study at the Department of Energy’s SLAC National Accelerator Laboratory suggests for the first time how scientists might deliberately engineer superconductors that work at higher temperatures.

When Chinese workers searching for water found the famous Terracotta Warriors instead, they brought to light a scientific mystery.

Scientists at Genentech and SLAC have watched a key human protein change from a form that protects cells to one that kills them, providing valuable new insights to cancer research.

Four-day Event Includes Presentations by Nobel Prize Winners, Other Science Luminaries

Annual Award Recognizes Behind-the-scenes Work in Assisting X-ray Experiments

Discovery at SLAC's Synchrotron Could Lead to New Drug Designs, Treatments

SSRL protein crystallography expert joined research effort that could lead to a safe and effective alternative to chemotherapy.

System Studied at SLAC's Synchrotron Mimics Steps in Photosynthesis